Top

Published in:

Open Access 01-09-2011 | Original Contribution

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells

Authors: I. Ahrens, H. Domeij, S. U. Eisenhardt, D. Topcic, M. Albrecht, E. Leitner, K. Viitaniemi, J. B. Jowett, M. Lappas, C. Bode, I. Haviv, K. Peter

Published in: Basic Research in Cardiology | Issue 5/2011

Abstract

C-reactive protein (CRP) has been linked to the pathogenesis of atherosclerosis. The dissociation of native, pentameric (p)CRP to monomeric (m)CRP on the cell membrane of activated platelets has recently been demonstrated. The dissociation of pCRP to mCRP may explain local pro-inflammatory reactions at the site of developing atherosclerotic plaques. As a biomarker, pCRP predicts cardiovascular adverse events and so do reduced levels and function of circulating endothelial progenitor cells (EPCs). We hypothesised that mCRP and pCRP exert a differential effect on EPC function and differentiation. EPCs were treated with mCRP or pCRP for 72 h, respectively. Phenotypical characterisation was done by flow cytometry and immunofluorescence microscopy, while the effect of mCRP and pCRP on gene expression was examined by whole-genome gene expression analysis. The functional capacity of EPCs was determined by colony forming unit (CFU) assay and endothelial tube formation assay. Double staining for acetylated LDL and ulex lectin significantly decreased in cells treated with pCRP. The length of tubuli in a matrigel assay with HUVECs decreased significantly in response to pCRP, but not to mCRP. The number of CFUs increased after pCRP treatment. RNA expression profiling demonstrated that mCRP and pCRP cause highly contradictory gene regulation. Interferon-responsive genes (IFI44L, IFI44, IFI27, IFI 6, MX1, OAS2) were among the highly up-regulated genes after mCRP, but not after pCRP treatment. In conclusion, EPC phenotype, genotype and function were differentially affected by mCRP and pCRP, strongly arguing for differential roles of these two CRP conformations. The up-regulation of interferon-inducible genes in response to mCRP may constitute a mechanism for the local regulation of EPC function.

Available only for authorised users

Ahrens I, Domeij H, Topcic D, Mirivirta R, Bode C, Lappas M, Peter K (2010) Successful in vitro expansion and differentiation of cord blood derived CD34+ cells into functionally active endothelial progenitor cells. Eur Heart J 31:279–587 (P2341). doi:10.1093/eurheartj/ehq288

Albert MA, Glynn RJ, Ridker PM (2003) Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108:161–165. doi:10.1161/01.CIR.0000080289.72166.CF PubMedCrossRef

Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–967. doi:10.1126/science.275.5302.964 PubMedCrossRef

Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, Pascual V (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 197:711–723. doi:10.1084/jem.20021553 PubMedCrossRef

Blaschke F, Bruemmer D, Yin F, Takata Y, Wang W, Fishbein MC, Okura T, Higaki J, Graf K, Fleck E, Hsueh WA, Law RE (2004) C-reactive protein induces apoptosis in human coronary vascular smooth muscle cells. Circulation 110:579–587. doi:10.1161/01.CIR.0000136999.77584.A2 PubMedCrossRef

Bowman TV, Merchant AA, Goodell MA (2007) Molecular profiling of hematopoietic stem cells. Methods Mol Med 134:1–16. doi:10.1007/978-1-59745-223-6_1 PubMedCrossRef

Chen J, Huang L, Song M, Yu S, Gao P, Jing J (2009) C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J Cardiovasc Pharmacol 53:359–367. doi:10.1097/FJC.0b013e31819b5438 PubMedCrossRef

Choi JH, Kim KL, Huh W, Kim B, Byun J, Suh W, Sung J, Jeon ES, Oh HY, Kim DK (2004) Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler Thromb Vasc Biol 24:1246–1252. doi:10.1161/01.ATV.0000133488.56221.4a PubMedCrossRef

Ciulla MM, Giorgetti A, Silvestris I, Cortiana M, Montelatici E, Paliotti R, Annoni GA, Fiore AV, Giordano R, De Marco F, Magrini F, Rebulla P, Cortelezzi A, Lazzari L (2006) Endothelial colony forming capacity is related to C-reactive protein levels in healthy subjects. Curr Neurovasc Res 3:99–106. doi:10.2174/156720206776875876 PubMedCrossRef

10.

Coutts M, Cui K, Davis KL, Keutzer JC, Sytkowski AJ (1999) Regulated expression and functional role of the transcription factor CHOP (GADD153) in erythroid growth and differentiation. Blood 93:3369–3378PubMed

11.

Denny MF, Thacker S, Mehta H, Somers EC, Dodick T, Barrat FJ, McCune WJ, Kaplan MJ (2007) Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 110:2907–2915. doi:10.1182/blood-2007-05-089086 PubMedCrossRef

12.

Di Nardo A, Kramvis I, Cho N, Sadowski A, Meikle L, Kwiatkowski DJ, Sahin M (2009) Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner. J Neurosci 29(18):5926–5937. doi:10.1523/JNEUROSCI.0778-09.2009 PubMedCrossRef

13.

Dimmeler S (2010) Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance. Arterioscler Thromb Vasc Biol 30:1088–1093. doi:10.1161/ATVBAHA.109.191668 PubMedCrossRef

14.

Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95:14863–14868. doi:10.1073/pnas.96.19.10943-c PubMedCrossRef

15.

Eisenhardt SU, Habersberger J, Murphy A, Chen YC, Woollard KJ, Bassler N, Qian H, von Zur Muhlen C, Hagemeyer CE, Ahrens I, Chin-Dusting J, Bobik A, Peter K (2009) Dissociation of pentameric to monomeric C-reactive protein on activated platelets localizes inflammation to atherosclerotic plaques. Circ Res 105:128–137. doi:10.1161/CIRCRESAHA.108.190611 PubMedCrossRef

16.

Eisenhardt SU, Habersberger J, Oliva K, Lancaster GI, Ayhan M, Woollard KJ, Bannasch H, Rice GE, Peter K (2011) A proteomic analysis of C-reactive protein stimulated THP-1 monocytes. Proteome Sci 9:1. doi:10.1186/1477-5956-9-1 PubMedCrossRef

17.

Eisenhardt SU, Habersberger J, Peter K (2009) Monomeric C-reactive protein generation on activated platelets: the missing link between inflammation and atherothrombotic risk. Trends Cardiovasc Med 19:232–237. doi:10.1016/j.tcm.2010.02.002 PubMedCrossRef

18.

Friedrich EB, Werner C, Walenta K, Bohm M, Scheller B (2009) Role of extracellular signal-regulated kinase for endothelial progenitor cell dysfunction in coronary artery disease. Basic Res Cardiol 104:613–620. doi:10.1007/s00395-009-0022-6 PubMedCrossRef

19.

Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S (2006) C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 26:2476–2482. doi:10.1161/01.ATV.0000242794.65541.02 PubMedCrossRef

20.

George J, Goldstein E, Abashidze S, Deutsch V, Shmilovich H, Finkelstein A, Herz I, Miller H, Keren G (2004) Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur Heart J 25:1003–1008. doi:10.1016/j.ehj.2004.03.026 PubMedCrossRef

21.

Goossens P, Gijbels MJ, Zernecke A, Eijgelaar W, Vergouwe MN, van der Made I, Vanderlocht J, Beckers L, Buurman WA, Daemen MJ, Kalinke U, Weber C, Lutgens E, de Winther MP (2010) Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions. Cell Metab 12:142–153. doi:10.1016/j.cmet.2010.06.008 PubMedCrossRef

22.

Hahne F, Mehrle A, Arlt D, Poustka A, Wiemann S, Beissbarth T (2008) Extending pathways based on gene lists using InterPro domain signatures. BMC Bioinformatics 9:3. doi:10.1186/1471-2105-9-3 PubMedCrossRef

23.

He LP, Tang XY, Ling WH, Chen WQ, Chen YM (2010) Early C-reactive protein in the prediction of long-term outcomes after acute coronary syndromes: a meta-analysis of longitudinal studies. Heart 96:339–346. doi:10.1136/hrt.2009.174912 PubMedCrossRef

24.

Hirschi KK, Ingram DA, Yoder MC (2008) Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584–1595. doi:10.1161/ATVBAHA.107.155960 PubMedCrossRef

25.

Hu CH, Li ZM, Du ZM, Zhang AX, Rana JS, Liu DH, Yang DY, Wu GF (2010) Expanded human cord blood-derived endothelial progenitor cells salvage infarcted myocardium in rats with acute myocardial infarction. Clin Exp Pharmacol Physiol 37:551–556. doi:10.1111/j.1440-1681.2010.05347.x PubMedCrossRef

26.

Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, Littman DR, Weber C, Ley K (2003) Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med 9:61–67. doi:10.1038/nm810 PubMedCrossRef

27.

Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249–264. doi:10.1093/biostatistics/4.2.249 PubMedCrossRef

28.

Ji SR, Wu Y, Zhu L, Potempa LA, Sheng FL, Lu W, Zhao J (2007) Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m). FASEB J 21:284–294. doi:10.1096/fj.06-6722com PubMedCrossRef

29.

Jujo K, Ii M, Losordo DW (2008) Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 45:530–544. doi:10.1016/j.yjmcc.2008.08.003 PubMedCrossRef

30.

Kaplan MJ (2009) Premature vascular damage in systemic lupus erythematosus. Autoimmunity 42:580–586. doi:10.1080/08916930903002479 PubMedCrossRef

31.

Kaur S, Kumar TR, Uruno A, Sugawara A, Jayakumar K, Kartha CC (2009) Genetic engineering with endothelial nitric oxide synthase improves functional properties of endothelial progenitor cells from patients with coronary artery disease: an in vitro study. Basic Res Cardiol 104:739–749. doi:10.1007/s00395-009-0039-x PubMedCrossRef

32.

Khreiss T, Jozsef L, Hossain S, Chan JS, Potempa LA, Filep JG (2002) Loss of pentameric symmetry of C-reactive protein is associated with delayed apoptosis of human neutrophils. J Biol Chem 277:40775–40781. doi:10.1074/jbc.M205378200 PubMedCrossRef

33.

Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells. Circulation 109:2016–2022. doi:10.1161/01.CIR.0000125527.41598.68 PubMedCrossRef

34.

Khreiss T, Jozsef L, Potempa LA, Filep JG (2004) Opposing effects of C-reactive protein isoforms on shear-induced neutrophil-platelet adhesion and neutrophil aggregation in whole blood. Circulation 110:2713–2720. doi:10.1161/01.CIR.0000146846.00816.DD PubMedCrossRef

35.

Khreiss T, Jozsef L, Potempa LA, Filep JG (2005) Loss of pentameric symmetry in C-reactive protein induces interleukin-8 secretion through peroxynitrite signaling in human neutrophils. Circ Res 97:690–697. doi:10.1161/01.RES.0000183881.11739.CB PubMedCrossRef

36.

LeCouter J, Zlot C, Tejada M, Peale F, Ferrara N (2004) Bv8 and endocrine gland-derived vascular endothelial growth factor stimulate hematopoiesis and hematopoietic cell mobilization. Proc Natl Acad Sci USA 101:16813–16818. doi:10.1073/pnas.0407697101 PubMedCrossRef

37.

Lee PY, Li Y, Richards HB, Chan FS, Zhuang H, Narain S, Butfiloski EJ, Sobel ES, Reeves WH, Segal MS (2007) Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 56:3759–3769. doi:10.1002/art.23035 PubMedCrossRef

38.

Liu C, Wang S, Deb A, Nath KA, Katusic ZS, McConnell JP, Caplice NM (2005) Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: implications of contaminating presence of sodium azide in commercial preparation. Circ Res 97:135–143. doi:10.1161/01.RES.0000174612.90094.fd PubMedCrossRef

39.

Maksimowicz-McKinnon K, Selzer F, Manzi S, Kip KE, Mulukutla SR, Marroquin OC, Smitherman TC, Kuller LH, Williams DO, Wasko MC (2008) Poor 1-year outcomes after percutaneous coronary interventions in systemic lupus erythematosus: report from the National Heart, Lung, and Blood Institute Dynamic Registry. Circ Cardiovasc Interv 1:201–208. doi:10.1161/CIRCINTERVENTIONS.108.788745 PubMedCrossRef

40.

Molins B, Pena E, Vilahur G, Mendieta C, Slevin M, Badimon L (2008) C-reactive protein isoforms differ in their effects on thrombus growth. Arterioscler Thromb Vasc Biol 28:2239–2246. doi:10.1161/ATVBAHA.108.174359 PubMedCrossRef

41.

Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E, Houstis N, Daly MJ, Patterson N, Mesirov JP, Golub TR, Tamayo P, Spiegelman B, Lander ES, Hirschhorn JN, Altshuler D, Groop LC (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267–273. doi:10.1038/ng1180 PubMedCrossRef

42.

Namba T, Tanaka K, Ito Y, Ishihara T, Hoshino T, Gotoh T, Endo M, Sato K, Mizushima T (2009) Positive role of CCAAT/enhancer-binding protein homologous protein, a transcription factor involved in the endoplasmic reticulum stress response in the development of colitis. Am J Pathol 174:1786–1798. doi:10.2353/ajpath.2009.080864 PubMedCrossRef

43.

Noels H, Weber C (2011) Catching up with important players in atherosclerosis: type I interferons and neutrophils. Curr Opin Lipidol 22:144–145. doi:10.1097/MOL.0b013e328344780b PubMedCrossRef

44.

Nzeusseu Toukap A, Galant C, Theate I, Maudoux AL, Lories RJ, Houssiau FA, Lauwerys BR (2007) Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum 56:1579–1588. doi:10.1002/art.22578 PubMedCrossRef

45.

Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res Cardiol 105:703–712. doi:10.1007/s00395-010-0109-0 PubMedCrossRef

46.

Ott I, Keller U, Knoedler M, Gotze KS, Doss K, Fischer P, Urlbauer K, Debus G, von Bubnoff N, Rudelius M, Schomig A, Peschel C, Oostendorp RA (2005) Endothelial-like cells expanded from CD34+ blood cells improve left ventricular function after experimental myocardial infarction. FASEB J 19:992–994. doi:10.1096/fj.04-3219fje PubMed

47.

Padfield GJ, Tura O, Haeck ML, Short A, Freyer E, Barclay GR, Newby DE, Mills NL (2010) Circulating endothelial progenitor cells are not affected by acute systemic inflammation. Am J Physiol Heart Circ Physiol 298:H2054–H2061. doi:10.1152/ajpheart.00921.2009 PubMedCrossRef

48.

Poss J, Werner C, Lorenz D, Gensch C, Bohm M, Laufs U (2010) The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice. Basic Res Cardiol 105:725–735. doi:10.1007/s00395-010-0120-5 PubMedCrossRef

49.

Raponi M, Belly RT, Karp JE, Lancet JE, Atkins D, Wang Y (2004) Microarray analysis reveals genetic pathways modulated by tipifarnib in acute myeloid leukemia. BMC Cancer 4:56. doi:10.1186/1471-2407-4-56 PubMedCrossRef

50.

Richardson MR, Yoder MC (2011) Endothelial progenitor cells: quo vadis? J Mol Cell Cardiol 50:266–272. doi:10.1016/j.yjmcc.2010.07.009 PubMedCrossRef

51.

Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836–843PubMedCrossRef

52.

Ryu J, Lee CW, Shin JA, Park CS, Kim JJ, Park SJ, Han KH (2007) FcgammaRIIa mediates C-reactive protein-induced inflammatory responses of human vascular smooth muscle cells by activating NADPH oxidase 4. Cardiovasc Res 75:555–565. doi:10.1016/j.cardiores.2007.04.027 PubMedCrossRef

53.

Sandstedt J, Jonsson M, Lindahl A, Jeppsson A, Asp J (2010) C-kit+ CD45− cells found in the adult human heart represent a population of endothelial progenitor cells. Basic Res Cardiol 105:545–556. doi:10.1007/s00395-010-0088-1 PubMedCrossRef

54.

Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM (2006) Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 355:1210–1221. doi:10.1056/NEJMoa060186 PubMedCrossRef

55.

Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM (2005) Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111:2981–2987. doi:10.1161/CIRCULATIONAHA.104.504340 PubMedCrossRef

56.

Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA (2006) C-reactive protein: a family of proteins to regulate cardiovascular function. Am J Kidney Dis 47:212–222. doi:10.1053/j.ajkd.2005.10.028 PubMedCrossRef

57.

Sherer Y, Zinger H, Shoenfeld Y (2010) Atherosclerosis in systemic lupus erythematosus. Autoimmunity 43:98–102. doi:10.3109/08916930903374527 PubMedCrossRef

58.

Steinmetz M, Nickenig G, Werner N (2011) Endothelial-regenerating cells: an expanding universe. Hypertension 55:593–599. doi:10.1161/HYPERTENSIONAHA.109.134213 CrossRef

59.

Tan Y, Yu F, Yang H, Chen M, Fang Q, Zhao MH (2008) Autoantibodies against monomeric C-reactive protein in sera from patients with lupus nephritis are associated with disease activity and renal tubulointerstitial lesions. Hum Immunol 69:840–844. doi:10.1016/j.humimm.2008.09.006 PubMedCrossRef

60.

Thacker SG, Duquaine D, Park J, Kaplan MJ (2010) Lupus-prone New Zealand black/New Zealand white F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus 19:288–299. doi:10.1177/0961203309353773 PubMedCrossRef

61.

Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J (2009) Endothelial progenitor cells: identity defined? J Cell Mol Med 13:87–102. doi:10.1111/j.1582-4934.2008.00598.x PubMedCrossRef

62.

Tsuzuki M (2009) Bone marrow-derived cells are not involved in reendothelialized endothelium as endothelial cells after simple endothelial denudation in mice. Basic Res Cardiol 104:601–611. doi:10.1007/s00395-009-0021-7 PubMedCrossRef

63.

Van Craenenbroeck EM, Hoymans VY, Beckers PJ, Possemiers NM, Wuyts K, Paelinck BP, Vrints CJ, Conraads VM (2010) Exercise training improves function of circulating angiogenic cells in patients with chronic heart failure. Basic Res Cardiol 105:665–676. doi:10.1007/s00395-010-0105-4 PubMedCrossRef

64.

Verma S, Kuliszewski MA, Li SH, Szmitko PE, Zucco L, Wang CH, Badiwala MV, Mickle DA, Weisel RD, Fedak PW, Stewart DJ, Kutryk MJ (2004) C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109:2058–2067. doi:10.1161/01.CIR.0000127577.63323.24 PubMedCrossRef

65.

Vosters O, Lombard C, Andre F, Sana G, Sokal EM, Smets F (2010) The interferon-alpha and interleukin-10 responses in neonates differ from adults, and their production remains partial throughout the first 18 months of life. Clin Exp Immunol 162:494–499. doi:10.1111/j.1365-2249.2010.04267.x PubMedCrossRef

66.

Walenta KL, Bettink S, Bohm M, Friedrich EB (2010) Differential chemokine receptor expression regulates functional specialization of endothelial progenitor cell subpopulations. Basic Res Cardiol 106:299–305. doi:10.1007/s00395-010-0142-z PubMedCrossRef

67.

Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G (2005) Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999–1007. doi:10.1056/NEJMoa043814 PubMedCrossRef

68.

Werner N, Nickenig G (2006) Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 10:318–332. doi:10.1111/j.1582-4934.2006.tb00402.x PubMedCrossRef

69.

Yoder MC (2009) Defining human endothelial progenitor cells. J Thromb Haemost 7(Suppl 1):49–52. doi:10.1111/j.1538-7836.2009.03407.x PubMedCrossRef

70.

Yu Y, Gao Y, Qin J, Kuang CY, Song MB, Yu SY, Cui B, Chen JF, Huang L (2010) CCN1 promotes the differentiation of endothelial progenitor cells and reendothelialization in the early phase after vascular injury. Basic Res Cardiol 105:713–724. doi:10.1007/s00395-010-0117-0 PubMedCrossRef

71.

Zimmermann O, Bienek-Ziolkowski M, Wolf B, Vetter M, Baur R, Mailander V, Hombach V, Torzewski J (2009) Myocardial inflammation and non-ischaemic heart failure: is there a role for C-reactive protein? Basic Res Cardiol 104:591–599. doi:10.1007/s00395-009-0026-2 PubMedCrossRef

72.

Zouki C, Haas B, Chan JS, Potempa LA, Filep JG (2001) Loss of pentameric symmetry of C-reactive protein is associated with promotion of neutrophil–endothelial cell adhesion. J Immunol 167:5355–5361PubMed

Title: Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells
Authors: I. Ahrens
H. Domeij
S. U. Eisenhardt
D. Topcic
M. Albrecht
E. Leitner
K. Viitaniemi
J. B. Jowett
M. Lappas
C. Bode
I. Haviv
K. Peter
Publication date: 01-09-2011
Publisher: Springer-Verlag
Published in: Basic Research in Cardiology / Issue 5/2011
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-011-0191-y

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models

Oxidative stress-induced formation of a positive-feedback loop for the sustained activation of p38 MAPK leading to the loss of cell division in cardiomyocytes soon after birth

Necrotic cell death in atherosclerosis

NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studies

Does mild hypothermia protect against reperfusion injury? The debate continues

OxLDL and macrophage survival: essential and oxygen-independent involvement of the Hif-pathway